Volume 14 (2023)
Volume 13 (2022)
Volume 12 (2021)
Volume 11 (2020)
Volume 10 (2019)
Volume 9 (2018)
Volume 8 (2017)
Volume 7 (2016)
Volume 6 (2015)
Volume 5 (2014)
Volume 4 (2013)
Volume 3 (2012)
Volume 2 (2011)
Volume 1 (2010)

Middle East Journal of Cancer (MEJC) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer in the Middle East, where cancer is becoming a growing health problem. Lastly, MEJC would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication. From June 1, 2020, the payment of a processing and publication charges are mandatory (for Iranian authors) for all types of manuscripts sent to the Middle East Journal of Cancer (MEJC).

MEJC is indexed in the Thomson Reuters Web of Science: Emerging Sources Citation Index (ESCI), a new edition of Web of Science™. All articles starting from 2015, will be included in this index.


Middle East Journal of Cancer has now received an impact factor of 0.4

Review Article(s)

Original Article(s)

Middle East Special Report

Letter to the Editor

Calendar of Events

Review Article(s)

Original Article(s)

Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients

Ali Kaan Güren; Nargiz Majidova; İclal Çakır; Nadiye Sever; Erkam Kocaaslan; Pınar Erel; Yeşim Ağyol; Abdussamed Çelebi; Rukiye Arıkan; Selver Işık; Murat Sarı; Özlem Ercelep; İbrahim Vedat Bayoğlu; Osman Köstek

Articles in Press, Accepted Manuscript, Available Online from 11 August 2024

https://doi.org/10.30476/mejc.2024.102063.2071

Case Report(s)

Keywords Cloud

Related Journals